An open letter to the FDA regarding changes in reporting procedures for drugs and biologics proposed in the wake of the FIAU tragedy

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)273-284
Number of pages12
JournalControlled clinical trials
Volume17
Issue number4
DOIs
StatePublished - Jan 1 1996

ASJC Scopus subject areas

  • Pharmacology

Cite this